Association of adipokines with obesity in children and adolescents

Biomarkers in Medicine

Volumn 7, Issue 5, 2013, Pages 731-735

  Jaleel, Anila ^a   Aheed, Bilal ^a   Jaleel, Shahila ^b   Majeed, Rehan ^c   Zuberi, Adnan ^a   Khan, Sheheryar ^a   Ahmed, Bilal ^a   Shoukat, Farah ^a   Hashim, Haris ^a  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b Sheikh Zayed Postgraduate Medical Institute   (Pakistan)

^c Rawal Institute of Health Sciences   (Pakistan)

Author keywords

adiponectin; HOMA IR; inflammation; insulin; resistin; TNF ; visfatin

Indexed keywords

ADIPONECTIN; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884561464     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.41     Document Type: Article

References (34)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Obesity in the United States, 2009-2010. NCHS Data Brief. CDC, GA, USA (2012
2. Jafar TH, Qadri Z, Islam M, Hatcher J, Bhutta ZA, Chaturvedi N. Rise in childhood obesity with persistently high rates of under-nutrition among urban school-aged Indo-Asian children. Arch. Dis. Child. 93, 373-378 (2008
3. Bray GA. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89(6), 2583-2589 (2004
4. Allison DB, Fontaine KR, Manson JE, Stevens J, Van Itallie TB. Annual deaths attributable to obesity in the United States. JAMA 284, 1530-1538 (1999
5. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N. Engl. J. Med. 341, 1097-1105(1999
6. Ahima RS, Osei SY. Adipokines in obesity Front. Horm. Res. 36, 182-197 (2008
7. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11, 332-337 (2000
8. Fernàndez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42, 1367-1374 (1999
9. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor: A key component of the obesity-diabetes link. Diabetes 43, 1271-1278 (1994
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119 (1995
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Higher adipose tissue expression of tumor necrosis factor a in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415 (1995
12. Peraldi P, Spiegelman B. TNF-alpha and insulin resistance: Summary and future prospects. Mol. Cell. Biochem. 182, 169-175 (1998
13. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-alpha antibody [CDP571] on insulin sensitivity and glycaemic control in patients with NIDDM. Diabetes 45, 881-885 (1996
14. Frittitta L, Youngren JF, Sbraccia P et al. Higher adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 40, 282-289 (1997
15. Woo KS, Chook P, Yu CW et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 109, 1981-1986 (2004
16. Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects: Results from a cross-sectional study in Malmo, Sweden. Diabet. Med. 17(4), 299-307 (2000
17. Flier JS, Kahn CR, Roth J. Receptor, antireceptor antibodies and mechanism of insulin resistance. N. Eng. J. Med. 300(8), 413-419 (1979
18. Postman T, Kiessig ST. Enzyme immunoassay techniques: An overview. Immunol. Methods 150, 5-21 (1992
19. Bouhours-Nouet N, Gatelias P, Boux C F, Rouleau S, Coutant R. The insulin like growth factor 1 response to growth hormone is higher in prepubertal children with obesity and tall stature. J. Clin. Endocrin. Metab. 92(2), 629-635 (2007
20. Fukuhara A, Matsuda M, NishizawaM et al. Visfatin: Apoprotein secreted by visceral fat that mimics the effect of insulin. Science 307(5708), 426-430 (2005
21. Haider DG, Holzer G, Schaller G et al. The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr. 43(4), 548-549 (2006
22. Berndt J, Klöting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54(10), 2911-2916 (2005
23. Araki S, Dobashi K, Kubo K et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity 16(2), 384-388 (2008
24. Davutoglu M, Ozkaya M, Guler E et al. Plasma visfatin concentrations in childhood obesity: Relationships to insulin resistance and anthropometric indices. Swiss Med. Weekly 139(1-2), 22-27 (2009
25. Pagano C, Pilon C, Olivieri M et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J. Clin. Endocrinol. Metab. 91(8), 3165-3170 (2006
26. Chen MP, Chung FM, Chang DM et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with Type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 91(1), 295-299 (2006
27. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J et al. Serum concentration of visfatin in obese women. Metabolism 56(8), 1131-1134 (2007
28. Oh YJ, Nam HK, Rhie YJ, Park SH, Lee KH. Low serum adiponectin levels in Korean children with a family history of Type 2 diabetes mellitus. Horm. Res. Paediatr. 77, 382-387 (2012
29. Kadowaki T, Yamaushi T, Kubota N, Hara K, Ueki K, Tobi K. Adiponectin and adiponectin receptors in insulin resistance, diabetes and metabolic syndrome. J. Clin. Inves. 116, 1784-1792 (2006
30. Hara K, Yamaushi T, Imei Y, Manabi I, Nagai R, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int. Heart J. 48, 149-153 (2007
31. Lee JH, Chan JL, Yiannakouris N et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88, 4848-4856 (2003
32. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al. Serum resistin FIZZ3 protein is higher in obese humans. J. Clin. Endocrinol. Metab. 88, 5452-5455 (2003
33. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993
34. Borst SE. The role of TNF-alpha in insulin resistance. Endocrine 23, 177-182 (2004